Breaking News
Get 45% Off 0
🤖 Are you in? These 5 AI-picked stocks are up 15%+
Read article

Stock Markets Analysis & Opinion

Contribute
Zacks Investment Research
Full Plate Of Economic Data, Q4 Earnings By Zacks Investment Research - Jan 17, 2018

Thursday, January 18, 2018We certainly have new Q4 earnings data to pass along to our readers ahead of the bell this morning, but being Thursday we also have weekly Initial Jobless Claims. Beyond...

Zacks Investment Research
Company News For Jan 18, 2018 By Zacks Investment Research - Jan 17, 2018

Tiffany & Co’s (NYSE:TIF) shares rose 1.3% after reporting that its global comparable sales advanced 5% in the last two months of 2017Shares of CSX Corporation (NASDAQ:CSX) decreased...

Zacks Investment Research
Here's Why It Is Apt To Hold On To Chubb (CB) Stock Now By Zacks Investment Research - Jan 17, 2018

Chubb Limited (NYSE:CB) stands a good chance of leading the property and casualty insurance space, benefiting from compelling products and services. This Zacks Rank #3 (Hold) property and casualty...

Zacks Investment Research
M&A Waves Pushing Biotech ETFs Higher By Zacks Investment Research - Jan 17, 2018

The biotech corner of the broad healthcare sector is in the spotlight to start the New Year, as the new tax legislation has enticed U.S. companies to bring offshore cash back home, sparking waves of...

Zacks Investment Research
Stock Market News For Jan 18, 2018 By Zacks Investment Research - Jan 17, 2018

Strong earnings results led benchmarks to close in positive territory on Wednesday, with the Dow finishing above 26,000 for the first time. Moreover, all the three key U.S. indexes settled at new...

Zacks Investment Research
AXIS Capital (AXS) Posts Preliminary Catastrophe Loss Data By Zacks Investment Research - Jan 17, 2018

AXIS Capital Holdings Limited (NYSE:AXS) has recently announced preliminary estimates of its total net financial impact from fourth-quarter 2017 catastrophe and weather-related losses as well as its...

Zacks Investment Research
BioLineRx Cancer Drug Positive As Monotherapy In Phase IIa By Zacks Investment Research - Jan 17, 2018

BioLineRx Ltd (NASDAQ:BLRX) announced encouraging partial results from the monotherapy portion of a phase IIa COMBAT study, evaluating its lead pipeline candidate, BL-8040 (a CXCR4 antagonist), for...

Zacks Investment Research
Ferrellgas Unit To Sell Bridger Energy, Aims To Lower Debt By Zacks Investment Research - Jan 17, 2018

Ferrellgas Partners L.P. (NYSE:FGP) announced that its subsidiary Bridger Logistics will sell Bridger Energy, LLC to an undisclosed buyer. The financial consideration is yet to be revealed. The...

Zacks Investment Research
Builder Confidence Slips In January, Strains Of Growth Exist By Zacks Investment Research - Jan 17, 2018

The confidence level among the nation's homebuilders slipped slightly in the first month of 2018 after reaching an 18-year high in December 2017, according to the National Association of Home...

Zacks Investment Research
PPG Industries (PPG) Beats Q4 Earnings & Sales Estimates By Zacks Investment Research - Jan 17, 2018

PPG Industries Inc. (NYSE:PPG) reported net earnings from continuing operations of $184 million or 72 cents per share for fourth-quarter 2017, a roughly two-fold increase from the year ago figure of...

Zacks Investment Research
Texas Instruments (TXN) Analog & Embedded To Aid Q4 Earnings By Zacks Investment Research - Jan 17, 2018

Texas Instruments (NASDAQ:TXN) or TI is scheduled to report fourth-quarter 2017 earnings on Jan 23 after the bell.We expect the company to perform well driven by strength in several high-margin,...

Zacks Investment Research
Hancock Holding (HBHC) Beats On Q4 Earnings, Provisions Up By Zacks Investment Research - Jan 17, 2018

Hancock Holding Company (NASDAQ:HBHC) released its fourth-quarter and full-year 2017 results. Adjusted earnings per share for the quarter came in at 86 cents, surpassing the Zacks Consensus Estimate...

Continue with Apple
Continue with Google
or
Sign up with Email